Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
Robert Zeiser(University of Freiburg), Robert S. Negrin(Stanford University)
Cited by 393
Related Papers
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859
Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations
|Biology of Blood and Marrow Transplantation|2013|402
Immune modulatory effects of oncogenic KRAS in cancer
|Nature Communications|2020|373
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage
|Nature Medicine|2014|294
The Nlrp3 inflammasome regulates acute graft-versus-host disease
|The Journal of Experimental Medicine|2013|233